TOP - Daily

Very few physicians, when suggesting treatment options for patients with low-risk prostate cancer, recommend active surveillance. Read More ›

A new study is the first of its kind to show a possibility for improvement in memory and thought process speeds among breast cancer survivors. Read More ›

A national campaign to raise public awareness about the prevalence of fraudulent Internet pharmacies has been launched by the FDA. Read More ›

Because transplant recipients and lymphoma patients have immune systems that tend to be significantly depressed, they are more likely than the average person to get melanoma and to die of it, a Mayo Clinic review has found. Read More ›

A new study provides evidence that electronic health records (EHRs) enhance the quality of patient care in a community-based setting with multiple payers. Read More ›

Upon completion of a supervised program, more than 40% of older breast cancer survivors are insufficiently active. Read More ›

A new drug has been approved by the FDA for patients with colorectal cancer that has metastasized after treatment. Read More ›

A simple blood test has been created that can detect the beginning stages of cancer, before symptoms like coughing and weight loss start. Read More ›

The success rate of clinical trials for breast cancer drugs can increase by almost 50% when biological markers are used, according to new research from the University of Toronto Mississauga. Read More ›

Cancer treatment protocols is one reason a virtual monopoly is held by some cancer drug manufacturers, which in turn helps to create the high cost of cancer drugs in the United States, according to a commentary by 2 Mayo Clinic physicians in a recent issue of the journal Mayo Clinic Proceedings. Read More ›